A series of 15 chalcones-bearing substituents at positions 2, 4, and 5 of rings A and B were synthesized using microwave-assisted Claissen–Smichdt condensation and evaluated for their activity against Giardia lamblia and Green monkey kidney cells. Five compounds exhibited activity against G. lamblia at IC50’s <5 μM. The chalcone 3m exhibited the highest antigiardial activity (IC50 = 1.03 μM), even more than the positive control (metronidazole, IC50 = 1.4 μM), and selectivity (SI = 38.9). A preliminary SAR study suggested that electrophylicity has not relationship with antigiardiasic activity, and the docking study reveals that synthesized chalcones bind at zone 3 of colchicine site, therefore presumably the action mechanism of the synthesized chalcones does not follow the Michael acceptor mechanism.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Aguayo-Ortiz R, Méndez-Lucio O, Romo-Mancillas A, Castillo R, Yépez-Mulia L, Medina-Franco JL, Hernández-Campos A (2013) Molecular basis for benzimidazole resistance from a novel β-tubulin binding site model. J Mol Graph Model 45:26–37
Ankarklev J, Jerlström-Hultqvist J, Ringqvist E, Troell K, Svärd SG (2010) Behind the smile: cell biology and disease mechanisms of Giardia species. Nat Rev Microbiol 8:413–422
Cedillo-Rivera R, Chavez B, Gonzalez-Robles A, Tapia A, Yepez-Mulia L (2002) Physiology and ecology-in vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites. J Eukaryot Microbiol 49:201–208
Cohen FE, McKerrow JH, Kenyon GL, Li Z, Chen X, Gong B, Li R (1998) Inhibitors of metazoan parasite proteases. US Patent 1998-5739170, filled 30 Mar 1995, issued 14 Apr 1998
Ducki S, Mackenzie G, Lawrence NJ, Snyder JP (2005) Quantitative structure-activity relationship (5D-QSAR) study of combretastatin-like analogues as inhibitors of tubulin assembly. J Med Chem 48:457–465
Escobedo A, Almirall P, Robertson LJ, Franco RMB, Hanevik K, Morch K, Cimerman S (2010) Giardiasis: The ever-present threat of a neglected disease. Infect Disord Drug Targ 10:329–348
Fennell BJ, Naughton JA, Barlow J, Brennan G, Fairweather I, Hoey E, McFerran N, Trudgett A, Bell A (2008) Microtubules as antiparasitic drug targets. Expert Opin Drug Discov 3:501–518
Gaonkar SL, Vignesh UN (2017) Synthesis and pharmacological properties of chalcones: a review. Res Chem Intermed 43:6043–6077
Gomes M, Muratov E, Pereira M, Peixoto J, Rosseto L, Cravo P, Andrade C, Neves B (2017) Chalcone derivatives: promising starting points for drug design. Molecules 22:1210–1235
Guzmán-Ocampo DC, Aguayo-Ortiz R, Cano-González L, Castillo R, Hernández-Campos A, Dominguez L (2018) Effects of the protonation state of titratable residues and the presence of water molecules on nocodazole binding to β-tubulin. ChemMedChem 13:20–24
Halliez MC, Buret AG (2013) Extra-intestinal and long term consequences of Giardia duodenalis infections. World J Gastroenterol 19:8974–8985
Katiyar SK, Gordon VR, Mclaughlin GL, Edlind TD (1984) Antiprotozoal activities of benzimidazoles and correlations with β-tubulin sequence. Antimicrob Agents Chemother 38:2086–2090
Lee C, Yang W, Parr RG (1988) Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys Rev B 37:785–789
Li W, Sun H, Xu S, Zhu Z, Xu J (2017) Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures. Future Med Chem 9:1765–1794
Maestro, Schrödinger, LLC, New York, NY, 2019
Mocelo-Castell R, Villanueva-Novelo C, Cáceres-Castillo D, Carballo RM, Quijano-Quiñones RF, Quesadas-Rojas M, Cantillo-Ciau Z, Cedillo-Rivera R, Moo-Puc RE, Moujir LM, Mena-Rejón GJ (2015) 2-Amino-4-arylthiazole derivatives as anti-giardial agents: synthesis, biological evaluation and QSAR studies. Open Chem 13:1127–1136
Montes-Avila J, Díaz-Camacho SP, Sicairos-Félix J, Delgado-Vargas F, Rivero IA (2009) Solution-phase parallel synthesis of substituted chalcones and their antiparasitary activity against Giardia lamblia. Bioorg Med Chem 17:6780–6785
Pasupuleti V, Escobedo AA, Deshpande A, Thota P, Roman Y, Hernandez AV (2014) Efficacy of 5-nitroimidazoles for the treatment of giardiasis: a systematic review of randomized controlled trials. Plos Negl Trop Dis 8:e2733
Pérez-Pérez M-J, Priego E-M, Bueno O, Martins MS, Canela M-D, Liekens S (2016) Blocking blood flow to solid tumors by destabilizing tubulin: an approach to targeting tumor growth. J Med Chem 59:8685–8711
Pires SM, Fischer-Walker CL, Lanata CF, Devleesschauwer B, Hall AJ, Kirk MD, Duarte ASR, Black RE, Angulo FJ (2015) Aetiology-specific estimates of the global and regional incidence and mortality of diarrhoeal diseases commonly transmitted through food. PLoS ONE 10:e0142927
Oyedapo AO, Makanju VO, Adewunmi CO, Iwalewa EO, Adenowo TK (2004) Antitrichomonal activity of 1,3-diaryl-2-propen-1-ones on Trichomonas gallinae. Afr J Trad CAM 1:55–62
Rahman A, Choudhary MI, Thomsen WJ (2001) Bioassay techniques for drug development. Harwood Academic Publishers, Netherlands
Sahu NK, Balbhadra SS, Choudhary J, Kohli DV (2012) Exploring pharmacological significance of chalcone scaffold: a review. Curr Med Chem 19:209–225
Savioli L, Smith H, Thompson A (2006) Giardia and Cryptosporidium join the neglected diseases initiative’. Trends Parasitol 22:203–208
Thompson RCA (2000) Giardiasis as a re-emerging infectious disease and its zoonotic potential. Int J Parasitol 30:1259–1267
Upcroft P, Upcroft JA (2001) Drug targets and mechanisms of resistance in the anaerobic protozoa. Clin Microbiol Rev 14:150–164
Vonthron-Sénécheau C, Bernard-Weniger B, Ouattara M, Tra-Bi F, Kamenan A, Lobstein A, Brun R, Anton R (2003) In vitro antiplasmodial activity and cytotoxicity of ethnobotanically selected Ivorian plants. J Ethnopharmacol 87:221–222
Wani MY, Bhat AR, Azam A, Lee DH, Choi I, Athar F (2012) Synthesis and in vitro evaluation of novel tetrazole embedded 1,3,5-trisubstituted pyrazoline derivatives as Entamoeba histolytica growth inhibitors. Eur J Med Chem 54:845–854
Zhuang C, Zhang W, Sheng C, Zhang W, Xing C, Miao Z (2017) Chalcone: a privileged structure in medicinal chemistry. Chem Rev 117:7762–7810
Funding for this research was provided by Facultad de Química, Universidad Autónoma de Yucatan. The docking analysis was performed as part of the research project 256657 granted by the Consejo Nacional de Ciencia y Tecnología - México (CONACYT). In memory of Dr. José Antonio Manzanilla Cano (1964-2015), for his invaluable support.
Conflict of interest
The authors declare that they have no conflict of interest.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Cáceres-Castillo, D., Carballo, R.M., Quijano-Quiñones, R. et al. Synthesis, in vitro antigiardial activity, SAR analysis and docking study of substituted chalcones. Med Chem Res 29, 431–441 (2020). https://doi.org/10.1007/s00044-019-02492-5
- Substituted chalcones
- Antigiardial activity
- SAR analysis
- Docking study